Laura L Stafman

5PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 10, 2026
ST6Gal2 promotes α2,6-sialylation and aggressive phenotypes in neuroblastoma cells.

|Sep 26, 2026
Developmental Sialylation in Neuroblastoma and Neural-Crest-Derived Tumors.

|May 14, 2025
A Novel Rexinoid Agonist, UAB116, Decreases Metastatic Phenotype in Hepatoblastoma by Inhibiting the Wnt/β-Catenin Pathway via Upregulation of TRIM29.

Swatika Butey, Morgan L Brown, Janet R Julson

|Sep 15, 2019
Focal Adhesion Kinase Inhibition Contributes to Tumor Cell Survival and Motility in Neuroblastoma Patient-Derived Xenografts.

Laura L Stafman, Adele P Williams, Raoud Marayati

|May 04, 2018
FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts.

Evan F Garner, Adele P Williams, Laura L Stafman

Pageof 1

Frequent Collaborators

1 joint publications

Evan F Garner

1 joint publications

Swatika Butey

1 joint publications

Morgan L Brown

1 joint publications

Janet R Julson